{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:32:43Z","timestamp":1793039563558,"version":"4.5.0"},"reference-count":165,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.canlet.2024.217116","type":"journal-article","created":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T01:13:21Z","timestamp":1720919601000},"page":"217116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"special_numbering":"C","title":["Natural products reverse cisplatin resistance in the hypoxic tumor microenvironment"],"prefix":"10.1016","volume":"598","author":[{"given":"Chuansheng","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinpei","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunyun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3206-782X","authenticated-orcid":false,"given":"Hailin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenglai","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2024.217116_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2024.108642","article-title":"Cisplatin in the era of PARP inhibitors and immunotherapy","volume":"258","author":"Duan","year":"2024","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.canlet.2024.217116_bib2","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.7150\/thno.69424","article-title":"Platinum-based drugs for cancer therapy and anti-tumor strategies","volume":"12","author":"Zhang","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.canlet.2024.217116_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101059","article-title":"Single-cell transcriptome analysis reveals the association between histone lactylation and cisplatin resistance in bladder cancer","volume":"73","author":"Li","year":"2024","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.canlet.2024.217116_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114205","article-title":"Therapeutic strategies to overcome cisplatin resistance in ovarian cancer","volume":"232","author":"Song","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.canlet.2024.217116_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2021.103327","article-title":"Tumor hypoxia: the major culprit behind cisplatin resistance in cancer patients","volume":"162","author":"Devarajan","year":"2021","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.canlet.2024.217116_bib6","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41573-020-00114-z","article-title":"Natural products in drug discovery: advances and opportunities","volume":"20","author":"Atanasov","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.canlet.2024.217116_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2019.115150","article-title":"Application of natural products derivatization method in the design of targeted anticancer agents from 2000 to 2018","volume":"27","author":"Liu","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.canlet.2024.217116_bib8","article-title":"Platinum-based chemotherapy for early triple-negative breast cancer","volume":"9","author":"Mason","year":"2023","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.canlet.2024.217116_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115337","article-title":"A state-of-art of underlying molecular mechanisms and pharmacological interventions\/nanotherapeutics for cisplatin resistance in gastric cancer","volume":"166","author":"Gupta","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.canlet.2024.217116_bib10","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.mayocp.2019.01.034","article-title":"Current diagnosis and management of small-cell lung cancer","volume":"94","author":"Wang","year":"2019","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.canlet.2024.217116_bib11","article-title":"Advances in diagnosis and treatment of testicular cancer","volume":"379","author":"Chovanec","year":"2022","journal-title":"BMJ (Clinical research ed.)"},{"key":"10.1016\/j.canlet.2024.217116_bib12","doi-asserted-by":"crossref","first-page":"842","DOI":"10.3390\/cancers14030842","article-title":"Dose-intense cisplatin-based neoadjuvant chemotherapy increases survival in advanced cervical cancer: an up-to-date meta-analysis","volume":"14","author":"Nguyen","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.canlet.2024.217116_bib13","series-title":"NCCN Guidelines\u00ae Insights: Head and Neck Cancers, Version 1.2022: Featured Updates to the NCCN Guidelines, \u2026 Comprehensive Cancer \u2026","author":"Jj Caudell","year":"2022"},{"key":"10.1016\/j.canlet.2024.217116_bib14","doi-asserted-by":"crossref","first-page":"148","DOI":"10.2478\/raon-2019-0018","article-title":"Cisplatin and beyond: molecular mechanisms of action and drug resistance development in cancer chemotherapy","volume":"53","author":"Makovec","year":"2019","journal-title":"Radiol. Oncol."},{"key":"10.1016\/j.canlet.2024.217116_bib15","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1080\/1028415X.2020.1840035","article-title":"Neuroprotective effects of natural compounds on neurotoxin-induced oxidative stress and cell apoptosis","volume":"25","author":"Chen","year":"2022","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.canlet.2024.217116_bib16","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1007\/s00018-016-2130-4","article-title":"The DNA damage-induced cell death response: a roadmap to kill cancer cells, Cell","volume":"73","author":"Matt","year":"2016","journal-title":"Mol. Life Sci."},{"key":"10.1016\/j.canlet.2024.217116_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215793","article-title":"Glucose restriction induces ROS-AMPK-mediated CTR1 expression and increases cisplatin efficiency in NSCLC","volume":"543","author":"Zhang","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2024.217116_bib18","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.semcancer.2021.05.023","article-title":"Interference between copper transport systems and platinum drugs","volume":"76","author":"Arnesano","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.canlet.2024.217116_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.993030","article-title":"Copper deficiency affects the developmental competence of porcine oocytes matured in vitro","volume":"10","author":"Choi","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.canlet.2024.217116_bib20","doi-asserted-by":"crossref","first-page":"E4279","DOI":"10.1073\/pnas.1311749110","article-title":"Ctr2 regulates biogenesis of a cleaved form of mammalian Ctr1 metal transporter lacking the copper- and cisplatin-binding ecto-domain","volume":"110","author":"\u00d6hrvik","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.canlet.2024.217116_bib21","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3389\/fchem.2018.00377","article-title":"Relevance of copper and organic cation transporters in the activity and transport mechanisms of an anticancer cyclometallated gold(III) compound in comparison to cisplatin","volume":"6","author":"Spreckelmeyer","year":"2018","journal-title":"Front. Chem."},{"key":"10.1016\/j.canlet.2024.217116_bib22","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.7150\/jca.19029","article-title":"A role for the ATP7A copper transporter in tumorigenesis and cisplatin resistance","volume":"8","author":"Zhu","year":"2017","journal-title":"J. Cancer"},{"key":"10.1016\/j.canlet.2024.217116_bib23","first-page":"1312","article-title":"Copper-transporting P-type adenosine triphosphatase (ATP7B) is associated with cisplatin resistance","volume":"60","author":"Komatsu","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2024.217116_bib24","first-page":"987","article-title":"Copper efflux transporter (ATP7B) contributes to the acquisition of cisplatin-resistance in human oral squamous cell lines","volume":"18","author":"Yoshizawa","year":"2007","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.canlet.2024.217116_bib25","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12967-018-1471-1","article-title":"Cisplatin based therapy: the role of the mitogen activated protein kinase signaling pathway","volume":"16","author":"Achkar","year":"2018","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.canlet.2024.217116_bib26","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.biopha.2018.12.010","article-title":"Phytochemicals: current strategy to sensitize cancer cells to cisplatin","volume":"110","author":"Sun","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.canlet.2024.217116_bib27","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/ijc.20134","article-title":"Reduced levels of XPA, ERCC1 and XPF DNA repair proteins in testis tumor cell lines","volume":"110","author":"Welsh","year":"2004","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2024.217116_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113487","article-title":"Abnormal saccharides affecting cancer multi-drug resistance (MDR) and the reversal strategies","volume":"220","author":"Wang","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.canlet.2024.217116_bib29","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.biopha.2013.04.012","article-title":"Inhibition of P-glycoprotein and glutathione S-transferase-pi mediated resistance by fluoxetine in MCF-7\/ADM cells","volume":"67","author":"Zhang","year":"2013","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.canlet.2024.217116_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104637","article-title":"Clinical efficacy and safety of aidi injection combination with vinorelbine and cisplatin for advanced non-small-cell lung carcinoma: a systematic review and meta-analysis of 54 randomized controlled trials","volume":"153","author":"Xiao","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.canlet.2024.217116_bib31","first-page":"2050","article-title":"miR-133b reverses cisplatin resistance by targeting GSTP1 in cisplatin-resistant lung cancer cells","volume":"41","author":"Lin","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.canlet.2024.217116_bib32","first-page":"989","article-title":"Glutathione S-transferase isozyme alpha 1 is predominantly involved in the cisplatin resistance of common types of solid cancer","volume":"41","author":"Zou","year":"2019","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.canlet.2024.217116_bib33","doi-asserted-by":"crossref","first-page":"6661","DOI":"10.1158\/0008-5472.CAN-07-5840","article-title":"Overcoming glutathione S-transferase P1-related cisplatin resistance in osteosarcoma","volume":"68","author":"Pasello","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2024.217116_bib34","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1186\/s13046-022-02522-y","article-title":"Targeting hypoxia in solid and haematological malignancies","volume":"41","author":"Harris","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2024.217116_bib35","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12943-019-1089-9","article-title":"Role of hypoxia in cancer therapy by regulating the tumor microenvironment","volume":"18","author":"Jing","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2024.217116_bib36","first-page":"518","article-title":"No erythropoietin-induced growth is observed in non-small cell lung cancer cells","volume":"52","author":"Frille","year":"2018","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.canlet.2024.217116_bib37","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1021\/acs.jnatprod.1c01166","article-title":"Discovery of natural ursane-type SENP1 inhibitors and the platinum resistance reversal activity against human ovarian cancer cells: a structure-activity relationship study","volume":"85","author":"Wei","year":"2022","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.canlet.2024.217116_bib38","article-title":"Unveiling the role of RAC3 in the growth and invasion of cisplatin-resistant bladder cancer cells","volume":"28","author":"Li","year":"2024","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.canlet.2024.217116_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910701","article-title":"Chronic and cycling hypoxia: drivers of cancer chronic inflammation through HIF-1 and NF-\u03baB activation: a review of the molecular mechanisms","volume":"22","author":"Korbecki","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2024.217116_bib40","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.neo.2014.11.003","article-title":"Cycling hypoxia induces a specific amplified inflammatory phenotype in endothelial cells and enhances tumor-promoting inflammation in vivo","volume":"17","author":"Tellier","year":"2015","journal-title":"Neoplasia"},{"key":"10.1016\/j.canlet.2024.217116_bib41","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nri.2017.142","article-title":"NF-\u03baB, inflammation, immunity and cancer: coming of age","volume":"18","author":"Taniguchi","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.canlet.2024.217116_bib42","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3390\/biom9080339","article-title":"Acute vs. Chronic vs. Cyclic hypoxia: their differential dynamics, molecular mechanisms, and effects on tumor progression","volume":"9","author":"Saxena","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.canlet.2024.217116_bib43","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1172\/JCI30049","article-title":"Antiinflammatory adaptation to hypoxia through adenosine-mediated cullin-1 deneddylation","volume":"117","author":"Khoury","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.canlet.2024.217116_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1244345","article-title":"Toll-like receptor-guided therapeutic intervention of human cancers: molecular and immunological perspectives","volume":"14","author":"Mukherjee","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2024.217116_bib45","doi-asserted-by":"crossref","first-page":"9176","DOI":"10.3390\/ijms24119176","article-title":"Role of p53 in cisplatin-induced myotube atrophy","volume":"24","author":"Matsumoto","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2024.217116_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212466","article-title":"Over fifty years of life, death, and cannibalism: a historical recollection of apoptosis and autophagy","volume":"22","author":"Izadi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2024.217116_bib47","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1111\/febs.13624","article-title":"The deadly landscape of pro-apoptotic BCL-2 proteins in the outer mitochondrial membrane","volume":"283","author":"Luna-Vargas","year":"2016","journal-title":"FEBS J."},{"key":"10.1016\/j.canlet.2024.217116_bib48","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.7150\/thno.29673","article-title":"Interaction between p53 and Ras signaling controls cisplatin resistance via HDAC4- and HIF-1\u03b1-mediated regulation of apoptosis and autophagy","volume":"9","author":"Zhang","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.canlet.2024.217116_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2021.109553","article-title":"Modeling hypoxia facilitates cancer cell survival through downregulation of p53 expression","volume":"345","author":"Zhang","year":"2021","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.canlet.2024.217116_bib50","doi-asserted-by":"crossref","first-page":"10212","DOI":"10.1093\/nar\/gkz766","article-title":"HIF-transcribed p53 chaperones HIF-1\u03b1","volume":"47","author":"Madan","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.canlet.2024.217116_bib51","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13046-024-02988-y","article-title":"Essential role of PLD2 in hypoxia-induced stemness and therapy resistance in ovarian tumors","volume":"43","author":"Mu\u00f1oz-Galv\u00e1n","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2024.217116_bib52","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12935-020-01729-3","article-title":"Hypoxia-induced Tie1 drives stemness and cisplatin resistance in non-small cell lung carcinoma cells","volume":"21","author":"Li","year":"2021","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.canlet.2024.217116_bib53","doi-asserted-by":"crossref","first-page":"794","DOI":"10.3892\/ol.2020.11589","article-title":"SATB2 knockdown decreases hypoxia-induced autophagy and stemness in oral squamous cell carcinoma","volume":"20","author":"Dong","year":"2020","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.canlet.2024.217116_bib54","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/j.ymthe.2019.05.017","article-title":"Hypoxia induces drug resistance in colorectal cancer through the HIF-1\u03b1\/miR-338-5p\/IL-6 feedback loop","volume":"27","author":"Xu","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.canlet.2024.217116_bib55","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.trsl.2023.05.005","article-title":"Norcantharidin potentiates sorafenib antitumor activity in hepatocellular carcinoma rat model through inhibiting IL-6\/STAT3 pathway","volume":"260","author":"Yousef","year":"2023","journal-title":"Transl. Res."},{"key":"10.1016\/j.canlet.2024.217116_bib56","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s12012-021-09646-1","article-title":"Morphine deteriorates cisplatin-induced cardiotoxicity in rats and induces dose-dependent cisplatin chemoresistance in MCF-7 human breast cancer cells","volume":"21","author":"El-Sheikh","year":"2021","journal-title":"Cardiovasc. Toxicol."},{"key":"10.1016\/j.canlet.2024.217116_bib57","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1080\/14728222.2020.1785431","article-title":"The role of microRNA in cisplatin resistance or sensitivity","volume":"24","author":"Wang","year":"2020","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.canlet.2024.217116_bib58","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.3892\/ijmm.2016.2529","article-title":"Overexpression of miR-155 promotes the proliferation and invasion of oral squamous carcinoma cells by regulating BCL6\/cyclin D2","volume":"37","author":"Zeng","year":"2016","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.canlet.2024.217116_bib59","doi-asserted-by":"crossref","first-page":"5402","DOI":"10.1158\/0008-5472.CAN-13-0297","article-title":"miR-205 targets PTEN and PHLPP2 to augment AKT signaling and drive malignant phenotypes in non-small cell lung cancer","volume":"73","author":"Cai","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2024.217116_bib60","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1021\/acs.molpharmaceut.1c00213","article-title":"MiR-155 inhibitor-laden exosomes reverse resistance to cisplatin in a 3D tumor spheroid and xenograft model of oral cancer","volume":"18","author":"Sayyed","year":"2021","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.canlet.2024.217116_bib61","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.3390\/cancers12051282","article-title":"Circulating MicroRNAs regulating DNA damage response and responsiveness to cisplatin in the prognosis of patients with non-small cell lung cancer treated with first-line platinum chemotherapy","volume":"12","author":"Papadaki","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.canlet.2024.217116_bib62","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1038\/jid.2010.63","article-title":"MicroRNA expression profiles associated with mutational status and survival in malignant melanoma","volume":"130","author":"Caramuta","year":"2010","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.canlet.2024.217116_bib63","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1002\/hep.30671","article-title":"Circular RNA MAT2B promotes glycolysis and malignancy of hepatocellular carcinoma through the miR-338-3p\/PKM2 Axis under hypoxic stress","volume":"70","author":"Li","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2024.217116_bib64","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.3389\/fonc.2020.01612","article-title":"CircHIPK3 promotes metastasis of gastric cancer via miR-653-5p\/miR-338-3p-NRP1 Axis under a long-term hypoxic microenvironment","volume":"10","author":"Jin","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2024.217116_bib65","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.3892\/or.2015.4195","article-title":"MicroRNA-338 inhibits migration and proliferation by targeting hypoxia-induced factor 1\u03b1 in nasopharyngeal carcinoma","volume":"34","author":"Shan","year":"2015","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.canlet.2024.217116_bib66","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.3892\/mmr.2015.3181","article-title":"MicroRNA-10a silencing reverses cisplatin resistance in the A549\/cisplatin human lung cancer cell line via the transforming growth factor-\u03b2\/Smad2\/STAT3\/STAT5 pathway","volume":"11","author":"Sun","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.canlet.2024.217116_bib67","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s10529-020-02846-9","article-title":"CircAKT3 inhibits glycolysis balance in lung cancer cells by regulating miR-516b-5p\/STAT3 to inhibit cisplatin sensitivity","volume":"42","author":"Xu","year":"2020","journal-title":"Biotechnol. Lett."},{"key":"10.1016\/j.canlet.2024.217116_bib68","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1074\/mcp.M900381-MCP200","article-title":"Hypoxic tumor cell modulates its microenvironment to enhance angiogenic and metastatic potential by secretion of proteins and exosomes","volume":"9","author":"Park","year":"2010","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.canlet.2024.217116_bib69","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.7150\/thno.51797","article-title":"Cisplatin-resistant NSCLC cells induced by hypoxia transmit resistance to sensitive cells through exosomal PKM2","volume":"11","author":"Wang","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.canlet.2024.217116_bib70","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/abbs\/gmx078","article-title":"Exosomes containing miR-21 transfer the characteristic of cisplatin resistance by targeting PTEN and PDCD4 in oral squamous cell carcinoma","volume":"49","author":"Liu","year":"2017","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"10.1016\/j.canlet.2024.217116_bib71","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1038\/s41388-018-0627-z","article-title":"Microenvironmental oxygen pressure orchestrates an anti- and pro-tumoral \u03b3\u03b4 T cell equilibrium via tumor-derived exosomes","volume":"38","author":"Li","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2024.217116_bib72","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s00262-020-02741-2","article-title":"OSCC cell-secreted exosomal CMTM6 induced M2-like macrophages polarization via ERK1\/2 signaling pathway","volume":"70","author":"Pang","year":"2021","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.canlet.2024.217116_bib73","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1158\/0008-5472.CAN-15-1625","article-title":"Exosomes derived from hypoxic oral squamous cell carcinoma cells deliver miR-21 to normoxic cells to elicit a prometastatic phenotype","volume":"76","author":"Li","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2024.217116_bib74","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1002\/hed.27460","article-title":"Hypoxia-induced tumor exosomes promote angiogenesis through miR-1825\/TSC2\/mTOR axis in oral squamous cell carcinoma","volume":"45","author":"Capik","year":"2023","journal-title":"Head Neck"},{"key":"10.1016\/j.canlet.2024.217116_bib75","article-title":"Matrix metalloproteinases in chemoresistance: regulatory roles, molecular interactions, and potential inhibitors","volume":"2022","author":"Tune","year":"2022","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.canlet.2024.217116_bib76","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1080\/15384101.2022.2051971","article-title":"LncRNA RP3-326I13.1 promotes cisplatin resistance in lung adenocarcinoma by binding to HSP90B and upregulating MMP13","volume":"21","author":"Zhou","year":"2022","journal-title":"Cell Cycle"},{"key":"10.1016\/j.canlet.2024.217116_bib77","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1111\/cas.15487","article-title":"Reticulocalbin3: a Ca(2+) homeostasis regulator that promotes esophageal squamous cell carcinoma progression and cisplatin resistance","volume":"113","author":"Cai","year":"2022","journal-title":"Cancer Sci."},{"key":"10.1016\/j.canlet.2024.217116_bib78","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.3390\/ijms14012085","article-title":"Pre-Treatment of platinum resistant ovarian cancer cells with an MMP-9\/MMP-2 inhibitor prior to cisplatin enhances cytotoxicity as determined by high content screening","volume":"14","author":"Laios","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2024.217116_bib79","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.1038\/s41388-018-0189-0","article-title":"Hypoxia-induced exosomes contribute to a more aggressive and chemoresistant ovarian cancer phenotype: a novel mechanism linking STAT3\/Rab proteins","volume":"37","author":"Dorayappan","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2024.217116_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119399","article-title":"Exosomal miR-4443 promotes cisplatin resistance in non-small cell lung carcinoma by regulating FSP1 m6A modification-mediated ferroptosis","volume":"276","author":"Song","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.canlet.2024.217116_bib81","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.2147\/OTT.S186922","article-title":"Hypoxic non-small-cell lung cancer cell-derived exosomal miR-21 promotes resistance of normoxic cell to cisplatin","volume":"12","author":"Dong","year":"2019","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.canlet.2024.217116_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111632","article-title":"Phytochemicals reverse P-glycoprotein mediated multidrug resistance via signal transduction pathways","volume":"139","author":"Ganesan","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.canlet.2024.217116_bib83","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.semcancer.2019.12.010","article-title":"Repurposing of plant alkaloids for cancer therapy: pharmacology and toxicology","volume":"68","author":"Efferth","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.canlet.2024.217116_bib84","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1177\/1753425918800555","article-title":"Matrine induces apoptosis via targeting CCR7 and enhances the effect of anticancer drugs in non-small cell lung cancer in vitro","volume":"24","author":"Pu","year":"2018","journal-title":"Innate Immun."},{"key":"10.1016\/j.canlet.2024.217116_bib85","doi-asserted-by":"crossref","first-page":"442","DOI":"10.3892\/mmr.2016.5999","article-title":"Matrine-induced apoptosis in Hep3B cells via the inhibition of MDM2","volume":"15","author":"Zhou","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.canlet.2024.217116_bib86","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3892\/ijo.2015.3023","article-title":"Matrine-induced autophagy regulated by p53 through AMP-activated protein kinase in human hepatoma cells","volume":"47","author":"Xie","year":"2015","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.canlet.2024.217116_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153580","article-title":"In vitro and in vivo anti-metastatic effect of the alkaliod matrine from Sophora flavecens on hepatocellular carcinoma and its mechanisms","volume":"87","author":"Dai","year":"2021","journal-title":"Phytomedicine"},{"key":"10.1016\/j.canlet.2024.217116_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2019.108726","volume":"310","author":"Xu","year":"2019","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.canlet.2024.217116_bib89","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24173127","article-title":"Fangchinoline, a bisbenzylisoquinoline alkaloid can modulate cytokine-impelled apoptosis via the dual regulation of NF-\u03baB and AP-1 pathways","volume":"24","author":"Jung","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.canlet.2024.217116_bib90","article-title":"Tetrandrine partially reverses multidrug resistance of human laryngeal cancer cells","volume":"48","author":"Li","year":"2020","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.canlet.2024.217116_bib91","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1021\/acs.jnatprod.1c00618","article-title":"A derivative of piperlongumine and ligustrazine as a potential thioredoxin reductase inhibitor in drug-resistant hepatocellular carcinoma","volume":"84","author":"Qian","year":"2021","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.canlet.2024.217116_bib92","article-title":"Ligustrazine inhibits the proliferation and migration of ovarian cancer cells via regulating miR-211","volume":"41","author":"Zhang","year":"2021","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.canlet.2024.217116_bib93","doi-asserted-by":"crossref","first-page":"559","DOI":"10.21037\/tcr-22-455","article-title":"Induction of ligustrazine apoptosis of A549 cells through activation of death receptor pathway","volume":"11","author":"Zheng","year":"2022","journal-title":"Transl. Cancer Res."},{"key":"10.1016\/j.canlet.2024.217116_bib94","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1039\/D1MO00156F","article-title":"Dauricine inhibits human pancreatic carcinoma cell proliferation through regulating miRNAs","volume":"17","author":"Jiang","year":"2021","journal-title":"Mol Omics"},{"key":"10.1016\/j.canlet.2024.217116_bib95","first-page":"4403","article-title":"Dauricine suppresses the growth of pancreatic cancer in vivo by modulating the Hedgehog signaling pathway","volume":"18","author":"Zhang","year":"2019","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.canlet.2024.217116_bib96","doi-asserted-by":"crossref","first-page":"3836","DOI":"10.1002\/ptr.7089","article-title":"Dauricine inhibits proliferation and promotes death of melanoma cells via inhibition of Src\/STAT3 signaling","volume":"35","author":"Deng","year":"2021","journal-title":"Phytother Res."},{"key":"10.1016\/j.canlet.2024.217116_bib97","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1080\/01635581.2020.1803932","article-title":"Alpha solanine: a novel natural bioactive molecule with anticancer effects in multiple human malignancies","volume":"73","author":"Hassan","year":"2021","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.canlet.2024.217116_bib98","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.lfs.2016.02.008","article-title":"Therapeutic effects of dendrosomal solanine on a metastatic breast tumor","volume":"148","author":"Mohsenikia","year":"2016","journal-title":"Life Sci."},{"key":"10.1016\/j.canlet.2024.217116_bib99","article-title":"Antitumor efficacy of \u03b1-solanine against pancreatic cancer in vitro and in vivo","volume":"9","author":"Lv","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2024.217116_bib100","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.219","article-title":"\u03b1-Solanine induces ROS-mediated autophagy through activation of endoplasmic reticulum stress and inhibition of Akt\/mTOR pathway","volume":"6","author":"Hasanain","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2024.217116_bib101","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/tox.23390","article-title":"Involvement of miRNAs in response to oxidative stress induced by the steroidal glycoalkaloid \u03b1-solanine in hepatocellular carcinoma cells","volume":"37","author":"Gouhar","year":"2022","journal-title":"Environ. Toxicol."},{"key":"10.1016\/j.canlet.2024.217116_bib102","doi-asserted-by":"crossref","first-page":"11035","DOI":"10.1021\/jf072423r","article-title":"Alpha-chaconine-reduced metastasis involves a PI3K\/Akt signaling pathway with downregulation of NF-kappaB in human lung adenocarcinoma A549 cells","volume":"55","author":"Shih","year":"2007","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.canlet.2024.217116_bib103","doi-asserted-by":"crossref","first-page":"240","DOI":"10.2174\/1574892813666180329163945","article-title":"Anti-cancer effect of \u03b1-solanine by down-regulating S100P expression in colorectal cancer cells, recent pat","volume":"13","author":"Ni","year":"2018","journal-title":"Anticancer Drug Discov"},{"key":"10.1016\/j.canlet.2024.217116_bib104","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ejphar.2015.12.020","article-title":"\u03b1-Solanine inhibits vascular endothelial growth factor expression by down-regulating the ERK1\/2-HIF-1\u03b1 and STAT3 signaling pathways","volume":"771","author":"Wen","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.canlet.2024.217116_bib105","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1002\/ptr.7861","article-title":"A review on phytoestrogens: current status and future direction","volume":"37","author":"Patra","year":"2023","journal-title":"Phytother Res."},{"key":"10.1016\/j.canlet.2024.217116_bib106","doi-asserted-by":"crossref","first-page":"6723","DOI":"10.21873\/anticanres.14695","article-title":"Anticancer efficacy and mechanism of amentoflavone for sensitizing oral squamous cell carcinoma to cisplatin","volume":"40","author":"Chen","year":"2020","journal-title":"Anticancer Res."},{"key":"10.1016\/j.canlet.2024.217116_bib107","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1007\/s13197-019-04113-w","article-title":"Grape seed extract: having a potential health benefits","volume":"57","author":"Gupta","year":"2020","journal-title":"J. Food Sci. Technol."},{"key":"10.1016\/j.canlet.2024.217116_bib108","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.3390\/antiox9121200","article-title":"Grape seed proanthocyanidins induce apoptosis and cell cycle arrest of HepG2 cells accompanied by induction of the MAPK pathway and NAG-1","volume":"9","author":"Wang","year":"2020","journal-title":"Antioxidants"},{"key":"10.1016\/j.canlet.2024.217116_bib109","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.3390\/ijms19082204","article-title":"Combinational proanthocyanidins and resveratrol synergistically inhibit human breast cancer cells and impact Epigenetic\u207bMediating machinery","volume":"19","author":"Gao","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2024.217116_bib110","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s12272-010-0808-y","article-title":"Quercetin-mediated cell cycle arrest and apoptosis involving activation of a caspase cascade through the mitochondrial pathway in human breast cancer MCF-7 cells","volume":"33","author":"Chou","year":"2010","journal-title":"Arch Pharm. Res. (Seoul)"},{"key":"10.1016\/j.canlet.2024.217116_bib111","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/cpr.12296","article-title":"Gold nanoparticle-conjugated quercetin inhibits epithelial-mesenchymal transition, angiogenesis and invasiveness via EGFR\/VEGFR-2-mediated pathway in breast cancer","volume":"49","author":"Balakrishnan","year":"2016","journal-title":"Cell Prolif."},{"key":"10.1016\/j.canlet.2024.217116_bib112","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047516","article-title":"Quercetin inhibits angiogenesis mediated human prostate tumor growth by targeting VEGFR- 2 regulated AKT\/mTOR\/P70S6K signaling pathways","volume":"7","author":"Pratheeshkumar","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2024.217116_bib113","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1016\/j.fct.2010.08.028","article-title":"Inhibition of angiogenesis by quercetin in tamoxifen-resistant breast cancer cells","volume":"48","author":"Oh","year":"2010","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.canlet.2024.217116_bib114","doi-asserted-by":"crossref","first-page":"966","DOI":"10.4161\/auto.7.9.15863","article-title":"Quercetin induces protective autophagy in gastric cancer cells: involvement of Akt-mTOR- and hypoxia-induced factor 1\u03b1-mediated signaling","volume":"7","author":"Wang","year":"2011","journal-title":"Autophagy"},{"key":"10.1016\/j.canlet.2024.217116_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216332","article-title":"Curcumin in cancer therapy: exploring molecular mechanisms and overcoming clinical challenges","volume":"570","author":"Wang","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2024.217116_bib116","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/s41598-020-57965-0","article-title":"The dual role of curcumin and ferulic acid in counteracting chemoresistance and cisplatin-induced ototoxicity","volume":"10","author":"Paciello","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2024.217116_bib117","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.3892\/or.2017.5637","article-title":"Curcumin induces apoptotic cell death and protective autophagy in human gastric cancer cells","volume":"37","author":"Li","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.canlet.2024.217116_bib118","doi-asserted-by":"crossref","DOI":"10.1111\/jfbc.13888","article-title":"Curcumin induced G2\/M cycle arrest in SK-N-SH neuroblastoma cells through the ROS-mediated p53 signaling pathway","volume":"45","author":"Ye","year":"2021","journal-title":"J. Food Biochem."},{"key":"10.1016\/j.canlet.2024.217116_bib119","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/carcin\/23.1.143","article-title":"Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: its suppression by ectopic expression of Bcl-2 and Bcl-xl","volume":"23","author":"Anto","year":"2002","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.canlet.2024.217116_bib120","doi-asserted-by":"crossref","first-page":"438","DOI":"10.3390\/ijms21020438","article-title":"Curcumin-mediated apoptotic cell death in papillary thyroid cancer and cancer stem-like cells through targeting of the JAK\/STAT3 signaling pathway","volume":"21","author":"Khan","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2024.217116_bib121","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.biopha.2017.10.059","article-title":"Galangin (GG) combined with cisplatin (DDP) to suppress human lung cancer by inhibition of STAT3-regulated NF-\u03baB and Bcl-2\/Bax signaling pathways","volume":"97","author":"Yu","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.canlet.2024.217116_bib122","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ejmech.2019.05.027","article-title":"Natural products as multidrug resistance modulators in cancer","volume":"176","author":"Kumar","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.canlet.2024.217116_bib123","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105325","article-title":"Astragaloside IV enhances cisplatin chemosensitivity in hepatocellular carcinoma by suppressing MRP2","volume":"148","author":"Qu","year":"2020","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.canlet.2024.217116_bib124","article-title":"The optimal adjuvant strategy of aidi injection with gemcitabine and cisplatin in advanced non-small cell lung cancer: a meta-analysis of 70 randomized controlled trials","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.canlet.2024.217116_bib125","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3389\/fphar.2018.00092","article-title":"Scutellarin increases cisplatin-induced apoptosis and autophagy to overcome cisplatin resistance in non-small cell lung cancer via ERK\/p53 and c-met\/AKT signaling pathways","volume":"9","author":"Sun","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.canlet.2024.217116_bib126","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejphar.2018.11.040","article-title":"Scutellarin synergistically enhances cisplatin effect against ovarian cancer cells through enhancing the ability of cisplatin binding to DNA","volume":"844","author":"Xie","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.canlet.2024.217116_bib127","doi-asserted-by":"crossref","first-page":"587","DOI":"10.2147\/OTT.S187426","article-title":"Scutellarin inhibits the metastasis and cisplatin resistance in glioma cells","volume":"12","author":"Tang","year":"2019","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.canlet.2024.217116_bib128","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2018.10.010","article-title":"Apigenin-induced HIF-1\u03b1 inhibitory effect improves abnormal glucolipid metabolism in Ang\u2161\/hypoxia-stimulated or HIF-1\u03b1-overexpressed H9c2 cells","volume":"62","author":"Zhu","year":"2019","journal-title":"Phytomedicine"},{"key":"10.1016\/j.canlet.2024.217116_bib129","doi-asserted-by":"crossref","first-page":"6791","DOI":"10.21873\/anticanres.14702","article-title":"Hypoxia-inducible factor-1\u03b1 suppression in ovarian clear-cell carcinoma cells by silibinin administration","volume":"40","author":"Miyazawa","year":"2020","journal-title":"Anticancer Res."},{"key":"10.1016\/j.canlet.2024.217116_bib130","doi-asserted-by":"crossref","unstructured":"K.Y. Peng, T.C. Chou, Osthole exerts inhibitory effects on hypoxic colon cancer cells via EIF2[formula: see text] phosphorylation-mediated apoptosis and regulation of HIF-1[Formula: see text], Am. J. Chin. Med.. 50 (20222022) 621-637-.","DOI":"10.1142\/S0192415X22500240"},{"key":"10.1016\/j.canlet.2024.217116_bib131","doi-asserted-by":"crossref","unstructured":"Y. Wang, J. Chen, Y. Huang, S. Yang, T. Tan, N. Wang, J. Zhang, C. Ye, M. Wei, J. Luo, X. Luo, Schisandrin B suppresses osteosarcoma lung metastasis in vivo by inhibiting the activation of the Wnt\/betacatenin and PI3K\/Akt signaling pathways, Oncol. Rep.. 47 (20222022) -.","DOI":"10.3892\/or.2022.8261"},{"key":"10.1016\/j.canlet.2024.217116_bib132","doi-asserted-by":"crossref","unstructured":"B. Wang, X. Wang, X. Tong, Y. Zhang, Schisandrin B inhibits cell viability and migration, and induces cell apoptosis by circ_0009112\/miR-708-5p Axis through PI3K\/AKT pathway in osteosarcoma, Front. Genet.. 11 (20202022) 588670-588670.","DOI":"10.3389\/fgene.2020.588670"},{"key":"10.1016\/j.canlet.2024.217116_bib133","doi-asserted-by":"crossref","unstructured":"L. Jin, X.M. Ma, T.T. Wang, Y. Yang, N. Zhang, N. Zeng, Z.G. Bai, J. Yin, J. Zhang, G.Q. Ding, Z.T. Zhang, Psoralen suppresses cisplatin-mediated resistance and induces apoptosis of gastric adenocarcinoma by disruption of the miR196a-HOXB7-HER2 Axis, Cancer Manag. Res.. 12 (20202022) 2803-2827-.","DOI":"10.2147\/CMAR.S248094"},{"key":"10.1016\/j.canlet.2024.217116_bib134","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1080\/10408398.2021.2000933","article-title":"Comprehensive review on signaling pathways of dietary saponins in cancer cells suppression","volume":"63","author":"Zhou","year":"2023","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.canlet.2024.217116_bib135","doi-asserted-by":"crossref","unstructured":"Z. Wang, M.Y. Li, Z.H. Zhang, H.X. Zuo, J.Y. Wang, Y. Xing, M. Ri, H.L. Jin, C.H. Jin, G.H. Xu, L.X. Piao, C.G. Jiang, J. Ma, X. Jin, Panaxadiol inhibits programmed cell death-ligand 1 expression and tumour proliferation via hypoxia-inducible factor (HIF)-1alpha and STAT3 in human colon cancer cells, Pharmacol. Res.. 155 (20202022) 104727-104727.","DOI":"10.1016\/j.phrs.2020.104727"},{"key":"10.1016\/j.canlet.2024.217116_bib136","doi-asserted-by":"crossref","unstructured":"C. Mi, X. Cao, K. Ma, M. Wei, W. Xu, Y. Lin, J. Zhang, T.Y. Wang, Digitoxin promotes apoptosis and inhibits proliferation and migration by reducing HIF-1alpha and STAT3 in KRAS mutant human colon cancer cells, Chem. Biol. Interact.. 351 (20222022) 109729-109729.","DOI":"10.1016\/j.cbi.2021.109729"},{"key":"10.1016\/j.canlet.2024.217116_bib137","doi-asserted-by":"crossref","unstructured":"M. Yao, R. Li, Z. Yang, Y. Ding, W. Zhang, W. Li, M. Liu, C. Zhao, Y. Wang, H. Tang, J. Wang, A. Wen, PP9, a steroidal saponin, induces G2\/M arrest and apoptosis in human colorectal cancer cells by inhibiting the PI3K\/Akt\/GSK3beta pathway, Chem. Biol. Interact.. 331 (20202022) 109246-109246.","DOI":"10.1016\/j.cbi.2020.109246"},{"key":"10.1016\/j.canlet.2024.217116_bib138","doi-asserted-by":"crossref","unstructured":"X. Zhang, Z. Liu, S. Chen, H. Li, L. Dong, X. Fu, A new discovery: total Bupleurum saponin extracts can inhibit the proliferation and induce apoptosis of colon cancer cells by regulating the PI3K\/Akt\/mTOR pathway, J. Ethnopharmacol.. 283 (20222022) 114742-114742.","DOI":"10.1016\/j.jep.2021.114742"},{"key":"10.1016\/j.canlet.2024.217116_bib139","doi-asserted-by":"crossref","unstructured":"Q. Lei, F. Qiang, D. Chao, W. Di, Z. Guoqian, Y. Bo, Y. Lina, Amelioration of hypoxia and LPS-induced intestinal epithelial barrier dysfunction by emodin through the suppression of the NF-kappaB and HIF-1alpha signaling pathways, Int. J. Mol. Med.. 34 (20142022) 1629-1639-.","DOI":"10.3892\/ijmm.2014.1965"},{"key":"10.1016\/j.canlet.2024.217116_bib140","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.cbi.2011.03.013","article-title":"Rhein inhibits angiogenesis and the viability of hormone-dependent and -independent cancer cells under normoxic or hypoxic conditions in vitro","volume":"192","author":"Fernand","year":"2011","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.canlet.2024.217116_bib141","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.7150\/ijbs.70447","article-title":"The versatile emodin: a natural easily acquired anthraquinone possesses promising anticancer properties against a variety of cancers","volume":"18","author":"Zhang","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.canlet.2024.217116_bib142","doi-asserted-by":"crossref","unstructured":"Y. Zhong, F. Le, J. Cheng, C. Luo, X. Zhang, X. Wu, F. Xu, Q. Zuo, B. Tan, Triptolide inhibits JAK2\/STAT3 signaling and induces lethal autophagy through ROS generation in cisplatinresistant SKOV3\/DDP ovarian cancer cells, Oncol. Rep.. 45 (20212022) -.","DOI":"10.3892\/or.2021.8020"},{"key":"10.1016\/j.canlet.2024.217116_bib143","doi-asserted-by":"crossref","unstructured":"X. Liu, J. Xu, J. Zhou, Q. Shen, Oridonin and its derivatives for cancer treatment and overcoming therapeutic resistance, Genes Dis. 8 (20212022) 448-462-.","DOI":"10.1016\/j.gendis.2020.06.010"},{"key":"10.1016\/j.canlet.2024.217116_bib144","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.3892\/ol.2017.6421","article-title":"Oridonin induces apoptosis and reverses drug resistance in cisplatin resistant human gastric cancer cells","volume":"14","author":"He","year":"2017","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.canlet.2024.217116_bib145","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ejmech.2019.04.005","article-title":"Synthesis, and evaluation of in vitro and in vivo anticancer activity of 14-substituted oridonin analogs: a novel and potent cell cycle arrest and apoptosis inducer through the p53-MDM2 pathway","volume":"173","author":"Shen","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.canlet.2024.217116_bib146","first-page":"1999","article-title":"Oridonin increases anticancer effects of lentinan in HepG2 human hepatoblastoma cells","volume":"15","author":"Sun","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.canlet.2024.217116_bib147","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/CAD.0000000000000329","article-title":"Inhibition of nuclear factor \u03baB transcription activity drives a synergistic effect of cisplatin and oridonin on HepG2 human hepatocellular carcinoma cells","volume":"27","author":"Dong","year":"2016","journal-title":"Anti Cancer Drugs"},{"key":"10.1016\/j.canlet.2024.217116_bib148","first-page":"330","article-title":"Fucoidan inhibits epithelial-to-mesenchymal transition via regulation of the HIF-1\u03b1 pathway in mammary cancer cells under hypoxia","volume":"18","author":"Li","year":"2019","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.canlet.2024.217116_bib149","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1080\/10717544.2018.1431980","article-title":"Developments in drug delivery of bioactive alkaloids derived from traditional Chinese medicine","volume":"25","author":"Zheng","year":"2018","journal-title":"Drug Deliv."},{"key":"10.1016\/j.canlet.2024.217116_bib150","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.113682","article-title":"Matrine: a review of its pharmacology, pharmacokinetics, toxicity, clinical application and preparation researches","volume":"269","author":"Li","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.canlet.2024.217116_bib151","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ejmech.2018.01.097","article-title":"Recent progress in the structural modification and pharmacological activities of ligustrazine derivatives","volume":"147","author":"Zou","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.canlet.2024.217116_bib152","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.113566","article-title":"Thirteen bisbenzylisoquinoline alkaloids in five Chinese medicinal plants: botany, traditional uses, phytochemistry, pharmacokinetic and toxicity studies","volume":"268","author":"Zhang","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.canlet.2024.217116_bib153","doi-asserted-by":"crossref","first-page":"7730","DOI":"10.1080\/10408398.2021.1917508","article-title":"Absorption, metabolism and bioavailability of flavonoids: a review","volume":"62","author":"Chen","year":"2022","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.canlet.2024.217116_bib154","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/dom.13868","article-title":"Safety and pharmacokinetics of naringenin: a randomized, controlled, single-ascending-dose clinical trial","volume":"22","author":"Rebello","year":"2020","journal-title":"Diabetes Obes. Metabol."},{"key":"10.1016\/j.canlet.2024.217116_bib155","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/biof.5520130125","article-title":"Recent studies on the biofunctions and biotransformations of curcumin","volume":"13","author":"Lin","year":"2000","journal-title":"Biofactors"},{"key":"10.1016\/j.canlet.2024.217116_bib156","doi-asserted-by":"crossref","first-page":"7307","DOI":"10.1021\/acsomega.9b04153","article-title":"The accumulation of psoralen contributes to its hepatotoxicity revealed by pharmacokinetic and toxicokinetic study after repeated administration","volume":"5","author":"Yang","year":"2020","journal-title":"ACS Omega"},{"key":"10.1016\/j.canlet.2024.217116_bib157","article-title":"Oridonin: a review of its pharmacology, pharmacokinetics and toxicity","volume":"12","author":"Li","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.canlet.2024.217116_bib158","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nrd.2018.183","article-title":"Non-invasive delivery strategies for biologics","volume":"18","author":"Anselmo","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.canlet.2024.217116_bib159","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1039\/C8NP00041G","article-title":"Interaction between gut microbiota and ethnomedicine constituents","volume":"36","author":"Wu","year":"2019","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.canlet.2024.217116_bib160","doi-asserted-by":"crossref","first-page":"D1324","DOI":"10.1093\/nar\/gkab913","article-title":"NPCDR: natural product-based drug combination and its disease-specific molecular regulation","volume":"50","author":"Sun","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.canlet.2024.217116_bib161","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1039\/D3NP00066D","article-title":"Controllable skeletal reorganizations in natural product synthesis","volume":"41","author":"Zhang","year":"2024","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.canlet.2024.217116_bib162","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12951-018-0392-8","article-title":"Nano based drug delivery systems: recent developments and future prospects","volume":"16","author":"Patra","year":"2018","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.canlet.2024.217116_bib163","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s13046-023-02724-y","article-title":"Novel cancer treatment paradigm targeting hypoxia-induced factor in conjunction with current therapies to overcome resistance","volume":"42","author":"Kao","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2024.217116_bib164","doi-asserted-by":"crossref","DOI":"10.1016\/j.copbio.2024.103137","article-title":"Cutting-edge plant natural product pathway elucidation","volume":"87","author":"Han","year":"2024","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.canlet.2024.217116_bib165","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.tplants.2024.02.008","article-title":"Spatial multi-omics in medicinal plants: from biosynthesis pathways to industrial applications","volume":"29","author":"Chen","year":"2024","journal-title":"Trends Plant Sci."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383524005111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383524005111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T19:42:26Z","timestamp":1760816546000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383524005111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":165,"alternative-id":["S0304383524005111"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2024.217116","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Natural products reverse cisplatin resistance in the hypoxic tumor microenvironment","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2024.217116","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"217116"}}